glp 1 mimetic mechanism of action of GLP-1 [25] GLP-1 receptor agonists in the

Lecithin-bound iodine prevents disruption of tight junctions of retinal pigment epithelial cells under hypoxic stress

Consult your GP for a comprehensive assessment rather than discontinuing GLP-1 therapy, as erectile dysfunction is unlikely to be directly caused by the medication

Complete prevention is not possible during active weight loss, but you can minimize severity by maintaining high protein intake (100-130g daily), starting a rigorous skincare routine with retinoids before treatment begins, and engaging in strength training to preserve facial muscle

Trial-Reported Endpoints by Phase Trial Lancet 2021 Phase 2 Duration 26 weeks Population Overweight/obese, no T2D (n=706) Mean Weight Loss 10.8% at 4.5 mg vs 3.0% placebo Trial Lancet 2023 Phase 2 Duration 32 weeks Population T2D + obesity (n=92) Mean Weight Loss 8.1% cagrilintide alone